tenk.fyi

MiNK Therapeutics, Inc.

INKTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$10.8M

52.0% YoY

EPS

$-2.86

56.3% YoY

Cash

$4.6M

35.9% YoY

FY 2024 · As of 2024-12-31